Connect with us

Technology

GenAI in Insurance: 3 key takeaways from a global industry survey

Published

on

Nearly 250 insurance decision makers share intel on GenAI strategy, sentiment and innovation

CARY, N.C., Oct. 15, 2024 /PRNewswire/ — Will generative AI prove itself a bane or boon to the insurance industry? A new study exploring the use of generative AI in insurance suggests that 9 in 10 insurers plan to invest in GenAI in the next year. The enthusiasm is palpable – but survey data also shows that the ethical and regulatory implications of innovation continue to vex many insurers, even as analytic ingenuity promises to help the sector address its biggest challenges.

“Insurance is a notoriously slow-moving industry, but insurers are proving to be GenAI trailblazers.”

The study, Your journey to a GenAI future: An insurer’s strategic path to success, comes from a global multi-industry survey by SAS, a data and AI company serving 47 of the world’s 50 largest global insurers, and Coleman Parks Research Ltd. Its findings offer an insider’s look at how insurance companies worldwide are implementing, budgeting for and strategizing around GenAI, based on survey insights from 236 industry decision makers. Additional insurance and cross-sector results from industries like banking, health care, life sciences and government can be compared and contrasted via SAS’ interactive GenAI survey data dashboard.

“Insurance is a notoriously slow-moving industry, but insurers are proving to be GenAI trailblazers, showing remarkable GenAI investment and excitement,” said Franklin Manchester, Principal Global Insurance Advisor at SAS. “We’re not looking at an AI bubble set to burst, and that’s a good thing – but it’s clear that the insurance sector, like other industries, has obstacles to overcome.

1. Insurers are jumping into GenAI…budget and strategy first.
With 89% of insurance sector respondents planning to invest in GenAI in 2025, 92% of that number have a dedicated GenAI budget in the works.

Among the industry’s goals for investing in GenAI, the top three emerged as:

Improvement in customer satisfaction and retention (81%, the highest of any industry segment).Reduction in operational costs and time savings (76%).Enhanced risk management and compliance measures (72%).

Already, two-thirds (68%) of insurance professionals surveyed reported using some form of GenAI in their professional roles at least once a week. About 1 in 5 (22%) professed they use the technology daily. While only 11% of respondents said their organization had fully implemented GenAI, another 49% indicated they were already in the process of implementing it.

“GenAI is not a silver bullet, but insurers are finding it can provide many more pieces of the jigsaw puzzle, including in areas that have previously proven quite difficult, like the ingestion of unstructured data,” said Joe Rowe, Data and AI Insurance Lead for UK, Ireland and Africa at Accenture. “Claims and underwriting are prime examples where GenAI is helping the human in the loop extract insights and make better decisions.”

2. Insurance expressed more concern about GenAI ethics than other industries.
Insurance decisionmakers showed themselves modestly more anxious about GenAI ethics than their counterparts in other industries. Among insurance respondents, 59% indicated concern about the ethical implications of their organization’s GenAI; that’s in contrast to a cross-industry average of 52%.

Despite insurers’ deeper ethics worries, their plans for governance and monitoring – efforts that would include the creation, implementation and maintenance of ethical frameworks – remain works in progress:

Only 5% of insurance respondents described their organization’s GenAI governance framework as “well-established and comprehensive.”57% reported that their organization’s frameworks were “in development.”27% called their organization’s frameworks “ad hoc or informal.”11% said their ethical frameworks were “nonexistent.”

“The use of GenAI is progressing quite rapidly, but to develop it responsibly, insurers must have an alignment of people, processes and technology, all working together to drive use cases from experimentation into operations and production,” said Rowe. “Proper governance requires focus and investment.”

In alignment with other industries, insurance pros named data privacy (cited by 75%) and data security (73%) as their foremost concerns related to their organizations’ use of GenAI. It’s little wonder; citizen fraudsters who employ GenAI – and career criminals employing the technology for larger scale frauds and financial crimes like money laundering and terrorism financing – are on the rise. In the fraud tech arms race, GenAI may well become table stakes to keep pace with bad actors.

3. Insurers look for answers for the data drought.
Complementing concerns about AI ethics are regulatory compliance worries. Only 1 in 10 (11%) of insurance respondents reported that their organization is fully prepared to comply with current and upcoming GenAI regulations. Ethically deployed GenAI use cases are drawing interest among insurers.

For instance, large language models (LLMs) require huge amounts of data which may not be available in existing productions systems to properly treat edge cases. There’s a serious lack of large datasets, combed for bias and checked for data quality, in insurance – a veritable data drought.

Why is this important? The quality and quantity of data used to train GenAI and other AI models can make or break the accuracy, fairness and equity of the model’s results in claims and policy decisions.

Furthermore, insurers, as fiduciaries, safeguard significant volumes of sensitive personal identifiable information. With data privacy anxiety growing, synthetic data ­– artificial data manufactured to realistically mimic real-world data, used to enrich existing datasets without compromising customer privacy – could provide an answer.

More than a quarter (27%) of insurance industry survey respondents reported using synthetic data; nearly a third (30%) said they were actively considering it, and 22% reported they might consider it.

“Many insurance decisionmakers are actively working on GenAI projects that could transform how carriers do business,” said Manchester. “Innovative spark is alive and well in insurance, and we can only nurture that flame when we embrace the tenets of responsible innovation. This includes establishing and maintaining policies and processes that protect customers and the integrity of the data we use.”

“The next step is clear: Insurers must embrace ethical frameworks and data rigor as their true north to realize the transformative potential – and full value – of GenAI technology.”

Unleashing the power of GenAI in insurance
As insurers navigate the risks and rewards of their GenAI journeys, it’s crucial to keep up with the latest data. How can insurers effectively and ethically implement GenAI? Dig into this exclusive research from Coleman Parks and SAS with experts from Microsoft, Accenture and FRG with a new webinar, Unleash the Power of Generative AI in Insurance, available now on demand.

About SAS
SAS is a global leader in data and AI. With SAS software and industry-specific solutions, organizations transform data into trusted decisions. SAS gives you THE POWER TO KNOW®.

SAS and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc. in the USA and other countries. ® indicates USA registration. Other brand and product names are trademarks of their respective companies. Copyright © 2024 SAS Institute Inc. All rights reserved.

Editorial Contact: 

Julia Norton               

Danielle Bates

julia.norton@sas.com

danielle.bates@sas.com 

919-531-4661   

919-531-1959

www.sas.com/news   

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/genai-in-insurance-3-key-takeaways-from-a-global-industry-survey-302276537.html

SOURCE SAS

Continue Reading

Technology

HEARTBOT AI Wins Chunghwa Telecom Special Award at Meet Neo Star 2026

Published

on

By

Named to the top 30 from more than 200 startups, AnyInsight won over judges with its zero-trust approach to AI governance

TAIPEI, Nov. 22, 2026 /PRNewswire/ — HEARTBOT AI has won the Chunghwa Telecom Special Award at Meet Neo Star 2026, the startup competition held during the Meet Taipei Startup Festival. CEO Nathan Yen pitched AnyInsight, the company’s enterprise AI security and governance platform, at the Meet Neo Star Demo Show Final on November 20, showing judges how companies can expand their use of AI agents without losing control of their data.

Alongside the judges’ awards, sponsors selected startups from the top 30 for their own prizes. HEARTBOT AI received the Chunghwa Telecom Special Award from Chunghwa Telecom (CHT), which includes priority eligibility for the final selection of the CHT 5G Accelerator Batch 9, CHT hicloud credits and opportunities to connect and collaborate with CHT business units.

Meet Taipei ran November 19 to 21 at Taipei Expo Park and drew more than 550 startups from 23 countries, its largest edition to date. In October, AnyInsight also received the ASOCIO Global Business Service Award.

Companies Want AI Agents, and Proof They Are Under Control

AI is moving beyond chat toward agents that read data, call internal systems and complete multistep tasks on their own. That changes what companies ask. The question is no longer which AI tools to use, but who can use them, what data they touch and what the agents actually did.

The gaps are already showing. Employees use personal AI accounts for work, leaving no company record. Agents built by individual teams run without IT’s knowledge, sometimes long after the people who built them have left. When auditors ask for AI usage records, teams spend weeks pulling them together by hand.

Regulation is adding pressure. The transparency obligations in Article 50 of the EU AI Act began applying in August 2026, and for Taiwanese companies that operate internationally, AI governance is now part of day-to-day operations.

One Platform for Models, Agents and Automated Workflows

AnyInsight is a zero-trust enterprise AI security and governance platform. Companies can build agents and automated workflows in a single environment, drawing on over 20 leading cloud models, 350-plus ready-to-use AI agents and more than 500 application connectors.

Every AI interaction passes through a zero-trust generative AI firewall, which uses context-aware semantic analysis to detect personal, financial and health data as well as cloud credentials, and can alert on, block or mask that content in real time. Before an agent calls a tool through the Model Context Protocol (MCP), AnyInsight checks policy and authorizes access by role under the principle of least privilege. High-risk actions require human approval, and every event is logged as exportable audit evidence.

AnyInsight Edge Takes Governance On-Premises

On November 12, HEARTBOT AI announced AnyInsight Edge, which extends the same governance to on-premises environments and AI servers. Many companies bound by data residency rules or regulation have already deployed private large language models, only to find them stuck as internal chatbots with no access to core systems such as ERP, MES and CRM.

Edge ships as a container, needs no GPU and can run in a company’s data center or integrate with an AI server’s operating system. A single control plane manages policy centrally and enforces it consistently across cloud and on-premises environments. On-premises models such as Gemma and Mistral get access to AnyInsight’s agents, automated workflows and connectors, while AI conversations, transferred data and audit logs can stay in-house.

“Companies stopped asking whether to use AI a while ago,” said Nathan Yen, CEO of HEARTBOT AI. “What holds them back is that once agents multiply, nobody can say for sure what data they touched or what they did. AnyInsight gives every AI interaction and every agent action an owner and a record. Once companies can see that, they’re willing to put AI into their core operations.”

“Recognition from the Meet Neo Star judges means a lot to a startup working on AI governance,” Yen said. “A growing number of companies now treat control as a condition for adopting AI, and that’s the problem we work on every day.”

About HEARTBOT AI

HEARTBOT AI develops trustworthy, high-assurance enterprise AI solutions. Its flagship platform, AnyInsight, is a zero-trust enterprise AI security and governance platform with a built-in generative AI firewall, role-based access control (RBAC) and auditable activity logs. AnyInsight helps organizations protect sensitive data and enforce AI governance across platforms and networks. Enterprises can securely and rapidly connect their data and business applications, adopt AI agents and automated workflows to boost productivity and knowledge management, and keep complete records ready for compliance audits.

AnyInsight is certified to ISO/IEC 27001:2022 for information security management, and its AI governance and data protection mechanisms are designed on the principles of the EU AI Act and the General Data Protection Regulation (GDPR).

More information: AnyInsight | HEARTBOT AI

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/heartbot-ai-wins-chunghwa-telecom-special-award-at-meet-neo-star-2026-302947562.html

SOURCE HEARTBOT AI Inc.

Continue Reading

Technology

ModuleMD Continues to Strengthen Its Position in Allergy EHR Innovation with a New Generation of AI-Powered Technology

Published

on

By

Following strong client interest in its new WISE Touch AI experience, ModuleMD showcases its expanding technology ecosystem at ACAAI 2026, bringing clinical intelligence, automated workflows and specialty-focused innovation together for allergy practices.

PHOENIX, Nov. 21, 2026 /PRNewswire/ —  Allergy practices are facing a new set of expectations. Clinical documentation needs to move faster. Front-office teams are managing increasingly complex administrative workflows. Patients expect greater transparency, while practices need technology that understands the demands of specialty care.

For more than 25 years, ModuleMD has built its technology around these realities. At the 2026 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting in Phoenix, Arizona, the company brought that commitment into focus, showcasing a new generation of AI-powered capabilities designed to advance how allergy and immunology practices deliver care and manage their operations.

At Booth #1713, the conversation centered on the continued development of the ModuleMD EHR platform, particularly its latest WISE Touch AI experience. The showcase also highlighted innovations in automated skin testing, clinical documentation, conversational practice intelligence and AI-powered front-office operations.

The momentum extends beyond the conference floor. Following its recent WISE Touch first-look webinar, ModuleMD has seen considerable interest and positive feedback from existing clients, reflecting growing enthusiasm for an EHR experience designed around the way specialty practices actually work.

An EHR Built Around Allergy. Now, With AI at Its Core.

Specialty healthcare technology requires more than a general-purpose EHR with a few specialty features added to it. Allergy practices have distinct clinical, operational and revenue cycle requirements, from immunotherapy and skin testing to biologics management and recurring patient workflows.

ModuleMD’s approach has been to build around these requirements from the ground up.

Its latest development, WISE Touch AI, brings a redesigned clinical experience and multiple AI-powered capabilities into one connected platform. Rather than treating artificial intelligence as a separate application, ModuleMD is integrating it into the everyday work of clinicians and practice teams.

The result is an EHR experience built around three important areas: clinical productivity, administrative automation and access to practice intelligence.

A redesigned clinical experience brings AI-assisted documentation, clinical decision support and CPT suggestions closer to the point of care. Designed around simpler interactions and fewer manual steps, WISE Touch AI aims to reduce the administrative effort involved in documenting and managing patient encounters.

AI-powered clinical documentation with JOSH™ takes this further. JOSH converts natural conversations into structured clinical notes, helping clinicians spend less time typing and more time with patients. Supporting more than 75 languages, the technology brings conversational documentation into the clinical workflow.

ModuleMD Front Desk extends AI into practice operations through five specialized agents working across patient intake, scheduling, insurance eligibility and estimates, authorizations and referrals, coordinated by a supervisor agent. The objective is to reduce repetitive administrative work while keeping essential front-office processes connected.

ModuleMDQ™ adds another dimension through conversational practice intelligence. Instead of navigating multiple screens to locate information, practice teams can interact with their practice data using natural language and get answers that help them move work forward.

Together, these capabilities reflect a broader direction for the ModuleMD EHR: clinical workflows, administrative operations and practice intelligence working as one system.

Rethinking Skin Testing Through AI

Innovation at ModuleMD also extends into some of the most specific workflows in allergy care.

Skin testing remains a fundamental part of allergy diagnostics, but measuring and documenting wheal and flare reactions can involve repetitive manual effort. ModuleMD’s SkinSight™ technology introduces image-based AI measurement into this process.

Using images captured on a device already available to the practice, SkinSight detects and measures wheal and flare reactions, with structured results and timestamped images transferred directly into the patient’s chart.

The integration of measurement, documentation and clinical records helps reduce manual data entry while giving clinicians the ability to review and interpret results. It also supports documentation for CPT 95004.

Developed with allergy-specific workflows in mind, SkinSight reflects an important distinction in ModuleMD’s approach to AI: technology should address actual clinical tasks, not simply introduce another layer of software.

Client Interest Signals a New Chapter for the ModuleMD EHR

Product innovation is only meaningful when it makes a difference to the people using it.

ModuleMD’s recent WISE Touch first-look webinar gave existing clients an opportunity to explore the new clinical experience and its connected AI capabilities. The response reflected strong interest in the direction of the platform, particularly the opportunity to bring clinical documentation, front-office automation and practice intelligence closer together.

For ModuleMD, this engagement is part of an ongoing relationship with the specialty practices that use its technology every day.

The company continues to develop its EHR around client needs, evolving clinical workflows and the operational realities of independent specialty practices. That means looking beyond individual features to how different parts of a practice work together.

The objective isn’t simply to add more functionality. It is to make the technology more useful at every point where clinicians and their teams interact with it.

More Than an EHR: A Connected Platform for Allergy Practices

ModuleMD’s platform brings together Electronic Health Records, Practice Management, Patient Engagement, Revenue Cycle Management, Allergy Immunotherapy, Biologics and Infusion Management.

This connected foundation is particularly important for allergy practices, where clinical care and practice operations are closely linked. From patient encounters and skin testing to immunotherapy workflows, biologics administration and revenue cycle management, the technology needs to support the full operational picture.

With more than 25 years of specialty healthcare experience, continued investment in AI and a platform shaped by the needs of its clients, ModuleMD is building on its position in allergy-focused healthcare technology.

Its presence at ACAAI 2026 offered a closer look at that direction: an EHR that continues to develop, AI that works within real practice workflows, and technology designed with the specific demands of allergy care at its center.

As specialty healthcare moves toward more connected and intelligent systems, ModuleMD’s focus remains on making technology work better for the practices that depend on it.

ModuleMD. One Practice. One Platform

To know more about ModuleMD visit www.modulemd.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/modulemd-continues-to-strengthen-its-position-in-allergy-ehr-innovation-with-a-new-generation-of-ai-powered-technology-302945885.html

SOURCE ModuleMD LLC

Continue Reading

Technology

GIGABYTE Partners with Newegg to Host “AORUS VS40” Esports Event for GIGABYTE’s 40th Anniversary

Published

on

By

CITY OF INDUSTRY, Calif., Nov. 21, 2026 /PRNewswire/ — Celebrating 40 years of GIGABYTE, GIGABYTE has partnered with Newegg to host AORUS VS40, a free community gaming celebration taking place on Saturday, November 21, 2026, from 11 a.m. to 4 p.m. PST at the Newegg Gamer Zone in Diamond Bar, California. The event invites local collegiate PC gamers, esports fans, and hardware enthusiasts to mark GIGABYTE’s 40-year milestone with competitive esports tournaments, hands-on hardware challenges, and exclusive gear.

Under the theme “PLAY. WIN. MAKE IT YOURS.”, AORUS VS40 features high-energy 1v1 competitions in VALORANT and League of Legends. To deliver peak competitive performance on the main stage, all tournament rigs are powered by GIGABYTE’s flagship AMD X870 motherboards and premium AMD Radeon graphics cards. The setups allow players to experience seamless gameplay, maximum frame rates, and low-latency response times during high-stakes tournament matches.

Beyond the competitive arena, attendees can explore interactive gaming stations throughout the venue. Visitors can test their response times in speed challenges on high-refresh GIGABYTE gaming monitors, get hands-on experience with the latest GIGABYTE gaming laptops, and participate in an event passport stamp activity to earn exclusive prizes. Additional event highlights include a custom tote bag heat-press station, hourly raffle prize drawings, limited-edition GIGABYTE 40th-anniversary merchandise, photo opportunities, and complimentary food and refreshments while supplies last.

The collaborative celebration between GIGABYTE, Newegg, and AMD reflects a shared commitment to empowering the Southern California gaming community. By bringing together top-tier hardware manufacturers and leading e-commerce platforms, AORUS VS40 offers local collegiate gamers and tech enthusiasts an immersive platform to connect, compete, and celebrate four decades of GIGABYTE’s impact on PC gaming.

“At Newegg, a lot of great builds have started with GIGABYTE parts, and we’re proud to celebrate GIGABYTE’s 40 years in PC gaming,” said Jim Tseng, Vice President of product management at Newegg. “Hosting this celebration at the Newegg Gamer Zone gives local gamers a day to compete, try the latest hardware, and take home something to remember it by.”

Admission to AORUS VS40 is complimentary, but advance RSVP via Eventbrite is strictly required as capacity is limited to 250 guests on a first-come, first-served basis. Attendees are encouraged to arrive early with their Eventbrite confirmation. Guests under 18 years of age must be accompanied by a parent or legal guardian, and additional age restrictions may apply to tournament participation. To reserve a spot or learn more, please visit [Eventbrite RSVP Link].

The Newegg Gamer Zone, a 2,300-square-foot gaming venue at Newegg’s headquarters, hosts esports tournaments, product launches, and community events throughout the year. It is open to the public Tuesday through Saturday, 10 a.m. to 7 p.m. PT. Walk-ins are welcome, or guests can reserve a visit. Gamers who can’t attend AORUS VS40 can find the GIGABYTE motherboards, graphics cards, monitors, and laptops featured at the event at Newegg.

About GIGABYTE

GIGABYTE is a developer, manufacturer, and distributor of high-performance hardware solutions. From award-winning monitors and graphics cards to advanced data center infrastructure, GIGABYTE remains committed to its mission of “Upgrade Your Life” through innovative technology and exceptional build quality.

About Newegg 

Newegg is the go-to destination for tech enthusiasts and businesses ready to power what’s next. For more than two decades, we’ve served builders, gamers, and IT professionals with a wide selection of PC hardware, consumer electronics, gaming peripherals, and lifestyle technology. Today, that includes the servers, workstations, and AI infrastructure that businesses rely on, along with the marketing, supply chain, and technical solutions that independent sellers use to grow. 

Newegg Commerce, Inc. (NASDAQ: NEGG) was founded in 2001 and is headquartered in Diamond Bar, California. For more information, please visit Newegg.com. 

Media Contacts
GIGABYTE
GIGABYTE USA PR Team
City of Industry, California
gbtusa_marketing@gigabyteusa.com

Newegg
Johnson Nei
Newegg Inc.
Public_relations@newegg.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/gigabyte-partners-with-newegg-to-host-aorus-vs40-esports-event-for-gigabytes-40th-anniversary-302945363.html

SOURCE GIGABYTE

Continue Reading

Trending